<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-vaccines-07-00074">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gray</surname>
    <given-names>E.S.</given-names>
   </name>
   <name>
    <surname>Moody</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Wibmer</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Marshall</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Amos</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Foulger</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>J.-S.</given-names>
   </name>
   <name>
    <surname>Lambson</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual</article-title>
  <source>J. Virol.</source>
  <year>2011</year>
  <volume>85</volume>
  <fpage>7719</fpage>
  <lpage>7729</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00563-11</pub-id>
  <?supplied-pmid 21613396?>
  <pub-id pub-id-type="pmid">21613396</pub-id>
 </element-citation>
</ref>
